Aptevo Therapeutics Inc.

Healthcare · Biotechnology · United States

Last price 1.34 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.41M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute mye...